Gastroesophageal reflux disease (GERD) is extremely common in our environment. Its diagnosis is complex. The Lyon Consensus defined, based on 24-hour pH monitoring, that an acid exposure time greater than 6% is definitely abnormal, less than 4% is normal, and between 4 and 6% is a gray area. The objective of this study is to describe the change in therapeutic behavior based on the result of prolonged pH recording performed with a 96-hour wireless pH measurement capsule in patients with GERD symptoms and an acid exposure time measured by impedanciometry/pH of 24 hours in the gray area. Also, describe the therapeutic outcomes.
Thirty consecutive patients with GERD symptoms and an acid exposure time (AET) measured by impedance measurement/pH between 4 and 6% will be included. A 96-hour off IBP wireless pH monitoring capsule will be performed. The worst day, the average of the 4 days and the presence of 2 or more days with AET\>6% and the 4 days with AET\<4% will be recorded. Patients will be categorized into GERD, reflux hypersensitivity, and functional heartburn. A treatment will be established based on these categories and the GERDq will be measured at 8 weeks of treatment.
Study Type
OBSERVATIONAL
Enrollment
30
The endoscopic pH measurement capsule will be placed 6cm above the squamocolumnar junction, determined endoscopically, in the sedated patient. Then the plot will be read.
Hospital de Clinicas Jose de San Martin. Buenos Aires University
Buenos Aires, Argentina
GERD Proportion
estimate the proportion of GERD measured by wireless pH monitoring capsule in patients in the gray area
Time frame: june 2021-june 2023
Therapeutic response
To compare the GERDq scale before and after treatment with proton pump inhibitors.
Time frame: june 2021-june 2023
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.